BIO-RAD LABORATORIES INC
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BIO-RAD LABORATORIES, INC. | |
|---|---|
| By: | /s/ Norman Schwartz |
| Norman Schwartz | |
| President and Chief Executive Officer | |
| Date: | February 16, 2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| /s/ Norman Schwartz | Chairman of the Board, President andChief Executive Officer, Principal Executive Officer, Principal Financial Officer | February 16, 2024 |
|---|---|---|
| (Norman Schwartz) | ||
| /s/ Tania Devilliers | Senior Director, Corporate Controller, | February 16, 2024 |
| (Tania Devilliers) | Interim Principal Accounting Officer | |
| Other Directors: | ||
| /s/ Jeffrey L. Edwards | Director | February 16, 2024 |
| (Jeffrey L. Edwards) | ||
| /s/ Gregory K. Hinckley | Director | February 16, 2024 |
| (Gregory K. Hinckley) | ||
| /s/ Melinda Litherland | Director | February 16, 2024 |
| (Melinda Litherland) | ||
| /s/ Arnold A. Pinkston | Director | February 16, 2024 |
| (Arnold A. Pinkston) | ||
| /s/ Allison Schwartz | Director | February 16, 2024 |
| (Allison Schwartz) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.